Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Long intergenic non-protein coding RNA 2278 (LINC02278)** is a human long intergenic non-coding RNA (lincRNA) gene that does not encode a protein and is located in a genomic region that does not overlap with protein-coding genes. LINC02278 is part of the broader lincRNA family, which are known for their roles in regulating chromatin states, genome architecture, and transcription, sometimes acting in enhancer-like manners or fine-tuning expression of neighboring genes with high tissue specificity. While thousands of lincRNAs exist and some have well-described regulatory or disease roles, no unique molecular function, disease association, or therapeutic targeting is currently described for LINC02278. Its biology, like many lincRNAs, is likely to be related to gene regulation, but functional studies for this specific gene are lacking[1][3].
Not applicable, as there are no drugs known to target LINC02278.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2278 (LINC02278).